Science-Business eXchange

, Volume 5, Issue 21, pp 537–537 | Cite as

Cooling down AD

  • Lev Osherovich


A Johns Hopkins University team has clinical proof-of-concept data for slowing the progression of Alzheimer's disease by reducing activity in the hippocampus with antiepileptic drugs. AgeneBio has licensed the IP and is planning a Phase II trial of an antiepileptic to prevent AD.

Copyright information

© Nature Publishing Group 2012

Authors and Affiliations

  • Lev Osherovich

There are no affiliations available

Personalised recommendations